New studies point to clot risk of Bayer's Yasmin contraceptive

New evidence emerged on Friday that women taking Bayer's best-selling contraceptive Yasmin may run a higher risk of dangerous blood clots than those using older birth-control pills. Two studies showed that users of pills containing drospirenone, one of the hormones used in Yasmin, had a two to threefold higher risk of venous thromboembolism than did users of those containing the older synthetic hormone levonorgestrel, according to British Medical Association. Reuters